So da es hier noch keine Runde zum Austausch des neuen Unternehmens gibt, starte ich mal.
 

....Tacrolimus Inhalation Powder and Topline Data for Voriconazole Inhalation Powder.

https://www.businesswire.com/news/home/...osing-Tacrolimus-Inhalation


 

BlackRock Inc. boosted its stake in shares of TFF Pharmaceuticals (NASDAQ:TFFP) by 77.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,134 shares of the company’s stock after purchasing an additional 9,682 shares during the quarter. BlackRock Inc. owned about 0.12% of TFF Pharmaceuticals worth $84,000 at the end of the most recent reporting period.

Separately, Goldman Sachs Group Inc. bought a new stake in shares of TFF Pharmaceuticals in the fourth quarter valued at about $85,000. 5.68% of the stock is owned by institutional investors and hedge funds.

https://theenterpriseleader.com/2020/06/20/...uticals-nasdaqtffp.html  

According to analysts' consensus price target of $15.00, TFF Pharmaceuticals has a potential upside of 140.4% from its current price of $6.24.

https://www.marketbeat.com/stocks/NASDAQ/TFFP/...tm_medium=backbutton

 

https://old.nasdaq.com/de/symbol/tffp/real-time

https://seekingalpha.com/article/...-results-earnings-call-transcript

https://www.pharmaceutical-business-review.com/...ff-pharmaceuticals/  

https://www.analystratings.com/articles/...asdaq-tffp-wont-stop-here/  

TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But Timidly

https://seekingalpha.com/article/...als-tffp-upside-catalysts-omicron